The global biotech ingredients market was valued at USD 62.1 Billion in 2024 and is projected to grow to USD 94.5 Billion by 2033, exhibiting a CAGR of 4.29% between 2025 and 2033. Europe currently dominates the market with a 37.6% share, driven by innovations in biotechnology, and increasing demand for sustainable biotech-derived ingredients across pharmaceuticals, cosmetics, and food & beverages. The market growth is fostered by rising eco-friendly and plant-based alternatives and strict regulations encouraging biotech solutions.
Study Assumption Years
Base Year: 2024
Historical Years: 2019-2024
Forecast Period: 2025-2033
Biotech Ingredients Market Key Takeaways
The global biotech ingredients market size was valued at USD 62.1 Billion in 2024.
The market is expected to reach USD 94.5 Billion by 2033, with a CAGR of 4.29% during 2025-2033.
Europe holds the largest market share of 37.6% in 2024.
Rising demand for natural and sustainable ingredients in food and beverage (F&B) sectors is impelling growth.
Advancements in biotechnology including fermentation and genetic engineering improve production efficiency and sustainability.
Increasing applications in pharmaceutical drug formulations, cosmetics, and personal care drive market expansion.
Regulatory policies are favoring the use of biotech-derived ingredients over synthetic chemicals.
Sample Request Link:
https://www.imarcgroup.com/Biotech-Ingredients-Market/requestsample
Market Growth Factors
The rising demand for natural and sustainable items in industries like food and beverage (F&B) is significantly impelling market growth. Consumers prefer eco-friendly and plant-based alternatives, encouraging companies to develop biotech-derived ingredients. This shift is accompanied by increased environmental and safety concerns, which favor bio-based products over synthetic or animal-based options, supporting the expanding adoption of biotech ingredients.
Advancements in biotechnology and synthetic biology are further catalyzing market growth. Innovations such as fermentation methodologies and gene editing allow for the effective formulation of high-quality ingredients with improved efficacy. The reduced reliance on traditional raw materials also minimizes environmental impacts and lowers production costs, fueling additional expansion opportunities across key sectors.
Increasing adoption of biotech ingredients by the personal care and cosmetic industries is another driver. Bio-based actives like hyaluronic acid, peptides, and enzymes offer better sustainability and superior performance such as enhanced skin hydration and anti-aging effects. This trend is prompting manufacturers to innovate and expand product offerings with biotech compounds, creating new growth avenues within the personal care segment.
Market Segmentation
Analysis by Type:
Yeast: Not detailed further in source.
Algae: Constituted 44.6% of the market share in 2024, driven by sustainable cultivation and high nutritional value. Algae-based ingredients are rich in essential fatty acids, antioxidants, and vitamins, extensively used in food & beverages, pharmaceuticals, and cosmetics. Examples include FDA-approved algae-based pharmaceutical products like Cresilon Inc’s Traumagel.
Others: Not detailed further in source.
Analysis by Application:
Food and Beverages: Not detailed further in source.
Personal Care and Cosmetics: Holds 38.7% market share, led by demand for effective, sustainable, and safe cosmetic ingredients such as enzymes, hyaluronic acid, and peptides, used for anti-aging and skincare. Companies like Debut are developing bio-identical ingredients for major brands like L'Oréal using advanced biomanufacturing.
Cleaning Products: Not detailed further in the source.
Others: Not detailed further in the source.
Regional Insights
Europe dominates the biotech ingredients market with a 37.6% share in 2024. The region's growth is propelled by strict regulations favoring natural and sustainable products, particularly in cosmetics and pharmaceuticals. Europe's expanding biotechnology infrastructure, robust R&D support from initiatives like Horizon Europe, and approvals for algae-based products foster this leadership. Countries such as France and Germany are central to innovation and manufacturing, sustaining Europe’s market dominance.
Recent Developments & News
December 2024: Estée Lauder Companies launched its BioTech Hub in Belgium focusing on bio-based ingredient alternatives from plant, yeast, and bacterial sources to enhance sustainability and innovation in skincare.
October 2024: Amyris secured a USD 12.3M contract from BioMaP-C to develop multiple small-molecule drugs on the FDA shortage list using synthetic biology and precision fermentation.
April 2024: Ole Hyva Luonnontuote introduced Meri, a cosmetic line replacing oil-based chemicals with seaweed-derived molecules, incorporating algae-derived alginate CAERULO by Origin by Ocean.
April 2024: GreenCoLab unveiled food prototypes including algae burgers and microalgae craft beer, emphasizing algae as a sustainable vegan ingredient.
January 2024: Danstar Ferment AG completed acquisition of Evolva AG, focusing on yeast-derived natural ingredients for flavors, fragrances, health products, and cosmetics.
Key Players
AbbVie Inc.
Advanced Biotech
Amyris Inc.
Becton Dickinson and Company
Bell Flavors & Fragrances Inc.
Bruker Corporation
Evolva AG
Evonik Industries AG
GlaxoSmithKline plc.
International Flavors & Fragrances Inc.
Merck KGaA
Sanofi SA
Get Custom Market Research Report for Your Business:
https://www.imarcgroup.com/request?type=report&id=3867&flag=E
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-201971-6302
